| Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912) |
|---|
| 05/28/2002 | US6395709 Methods and compositions for stimulating tissue growth and epithelial moisturization |
| 05/28/2002 | US6395707 Methods of treatment utilizing variants of vascular endothelial cell growth factor |
| 05/28/2002 | US6395705 Method and composition for treating irritable bowel syndrome using low doses of opioid receptor antagonists |
| 05/28/2002 | US6395511 Nuclelotide sequences coding regulatory protein; for usein treatment of bone disorders |
| 05/28/2002 | US6395494 Method to determine TGF-β |
| 05/28/2002 | US6395481 Methods for detection of promoter polymorphism in a UGT gene promoter |
| 05/28/2002 | US6395476 Evaluating long term outcome of viral disease infection; obtain sample, obtain viral nucleotide sequence from sample, screen sequences for presence of mutation in preferential codon, presence of mutation indicate more sever viral disease |
| 05/28/2002 | US6395474 Peptide nucleic acids |
| 05/28/2002 | US6395313 Ngali nut oil |
| 05/28/2002 | US6395310 Composition containing embryo bud and seed coat from rice and fruit body of Ganoderma lucidum for treating diabetes |
| 05/28/2002 | US6395308 For the treatment of asthma bronchiale, colitis ulcerosa, morbus crohn, diseases of the rheumatic type, and indications in which an increase of the lipoxygenase level occurs either by medicaments, other substances or diseases. |
| 05/28/2002 | US6395307 Forming a protective coating on gastrointestinal mucosal tissue for treating reflux oesophagitis, gastritis, dyspepsia or peptic ulceration |
| 05/28/2002 | US6395304 Apparatus and method for preparing microparticles |
| 05/28/2002 | US6395299 Matrices for drug delivery and methods for making and using the same |
| 05/28/2002 | US6395297 Transdermal preparation contacting a loratidine metabolite with antihistaminic activity |
| 05/28/2002 | US6395295 Otitis media, surface active phospholipid |
| 05/28/2002 | US6395293 Biodegradable implant precursor |
| 05/28/2002 | US6395291 Use for pain management |
| 05/28/2002 | US6395289 Hydrophilic polymer blends used to prevent cow skin infections |
| 05/28/2002 | US6395284 Mesomorphic complex of vitamin a acid and polyethyleneimine or poly-l-amino acid; treatment of skin disorders such as acne; antitumor agents |
| 05/28/2002 | US6395281 Cosmetic skin conditioning compositions containing red yeast rice extract |
| 05/28/2002 | US6395280 Deodorant agents for oral use for discharges and method for relieving odor of discharges |
| 05/28/2002 | US6395279 Mixture of at least two phytochemicals including isoflavones, lignins, saponins, catechins, and phenolic acids |
| 05/28/2002 | US6395270 Activated protein C formulations |
| 05/28/2002 | US6395260 Topical cosmetic compositions comprising benzaldoximes |
| 05/28/2002 | US6395254 Diagnosis of tumors and inflammatory disease |
| 05/28/2002 | US6394812 Vivo induction for enhanced function of isolated hepatocytes |
| 05/28/2002 | CA2325014C 8-chloro-6,11-dihydro-11-(4-piperidylidene)-5h-benzo[5,6]cyclohepta[1,2-b]pyridine oral compositions |
| 05/28/2002 | CA2254533C Treatment of pruritus |
| 05/28/2002 | CA2248006C Activated linkers and methods for making and purifying the same |
| 05/28/2002 | CA2222467C Novel derivatives of benzopyrane, process for preparing them and pharmaceutical compositions containing them |
| 05/28/2002 | CA2221091C Estrogen agonist/antagonists treatment of atherosclerosis |
| 05/28/2002 | CA2217710C Cancer metastasis inhibition with n-acetylneuramic acid |
| 05/28/2002 | CA2216386C Composition and process for prevention and treatment of cutaneous immediate hypersensitivity reactions |
| 05/28/2002 | CA2209513C Arachidonic acid and methods for the production and use thereof |
| 05/28/2002 | CA2207097C Quinazolinone-containing pharmaceutical compositions and methods for the use thereof |
| 05/28/2002 | CA2203618C New metalloprotease inhibitors, their preparation process and the pharmaceutical compounds that contain them |
| 05/28/2002 | CA2181377C Tetracyclic derivatives, process of preparation and use |
| 05/28/2002 | CA2165433C Novel chemical compounds having pde-iv inhibition activity |
| 05/28/2002 | CA2129855C Pressurized gas packagings using polyoxyethylene glyceryl-oleates |
| 05/28/2002 | CA2118997C Benzimidazole derivatives, their preparation and use |
| 05/28/2002 | CA2090104C Stabilized retinoid-containing skin care compositions |
| 05/28/2002 | CA2083274C The pharmacological use of certain cystine derivatives |
| 05/28/2002 | CA2073146C Octadecyl-[2-(n-methylpiperidino)-ethyl]-phosphate and a process for its preparation |
| 05/28/2002 | CA2073094C Germicidal compositions containing iodine compounds |
| 05/28/2002 | CA2064325C External preparation for application to the skin containing lidocaine |
| 05/28/2002 | CA2048300C Compositions containing a 4-quinolone derivative complexed with a divalent metal ion |
| 05/28/2002 | CA2038747C Selective adenosine receptor agents |
| 05/23/2002 | WO2002040700A2 Corticotropin releasing factor receptor 2 deficient mice and uses thereof |
| 05/23/2002 | WO2002040666A2 Fat regulated genes, uses thereof, and compounds for modulating same |
| 05/23/2002 | WO2002040629A2 Promoters exhibiting endothelial cell specificity and methods of using same |
| 05/23/2002 | WO2002040540A2 Artery smooth muscle- and vein smooth muscle-specific proteins and uses therefor |
| 05/23/2002 | WO2002040505A2 Dibenzoxazepine alpha v integrin receptor antagonist |
| 05/23/2002 | WO2002040489A1 Novel 4'-demethyl-4'-o-substituted-1-deoxypodophyllotoxin derivative and geometric isomer thereof, process for the preparation thereof and anti-cancer composition comprising the same |
| 05/23/2002 | WO2002040488A1 Novel photosensitizers of 9-hydroxypheophorbide-a derivatives used for photocynamic therapy |
| 05/23/2002 | WO2002040487A2 Benzodiazepine derivatives as gaba a receptor modulators |
| 05/23/2002 | WO2002040486A2 METHODS OF TREATING p38 KINASE-ASSOCIATED CONDITIONS AND PYRROLOTRIAZINE COMPOUNDS USEFUL AS KINASE INHIBITORS |
| 05/23/2002 | WO2002040485A1 Preventive or therapeutic medicines for diabetes containing fused-heterocycle compounds or their salts |
| 05/23/2002 | WO2002040484A2 Novel imidazole derivatives, production method thereof and use thereof |
| 05/23/2002 | WO2002040483A1 1-methylcarbapenem derivatives |
| 05/23/2002 | WO2002040480A2 Crf receptor antagonists and methods relating thereto |
| 05/23/2002 | WO2002040477A2 Saframycins, analogues and uses thereof |
| 05/23/2002 | WO2002040476A1 Pyridyl-substituted triazoles as tgf inhibitors |
| 05/23/2002 | WO2002040475A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040474A2 Heterocyclylalkyl piperidine derivatives and their use as antimicrobial agents |
| 05/23/2002 | WO2002040471A2 Tetrahydrobenzazepine derivatives useful as modulators of dopamine d3 receptors (antipsychotic agents) |
| 05/23/2002 | WO2002040469A1 Bombesin receptor antagonists |
| 05/23/2002 | WO2002040468A1 Compounds |
| 05/23/2002 | WO2002040466A2 Amidoalkyl-piperidine and amidoalkyl-piperazine derivatives for treating of nervous systems disorders |
| 05/23/2002 | WO2002040463A1 Macrocyclic compound |
| 05/23/2002 | WO2002040462A2 Cysteine protease inhibitors |
| 05/23/2002 | WO2002040458A1 Isoxazole derivatives |
| 05/23/2002 | WO2002040457A1 Piperazinylpyrazines compounds as antagonists of serotonin 5-ht2 receptor |
| 05/23/2002 | WO2002040456A1 Piperazinylpyrazine compounds as agonist or antagonist of serotonin 5ht-2 receptor |
| 05/23/2002 | WO2002040453A1 Substituted 2-phenylaminoimidazoline phenyl ketone derivatives as ip antagonists |
| 05/23/2002 | WO2002040451A2 Lactam compound |
| 05/23/2002 | WO2002040450A1 (dihydro)isoquinoline derivatives as phosphodiesterase inhibitors |
| 05/23/2002 | WO2002040448A1 Pyridone derivatives as ap2 inhibitors |
| 05/23/2002 | WO2002040446A1 Glucagon antagonist/inverse agonist |
| 05/23/2002 | WO2002040445A1 Glucagon antagonists/inverse agonists |
| 05/23/2002 | WO2002040070A2 Method for restoring a damaged or degenerated intervertebral disc |
| 05/23/2002 | WO2002040062A2 Improved ophthalmic and contact lens solutions with a peroxide source and a cationic polymeric preservative |
| 05/23/2002 | WO2002040058A2 Hydroxyapatite-targeting poly(ethylene glycol) and related polymers |
| 05/23/2002 | WO2002040057A1 Antibiotics adducts with natural polysaccharide polymers in the form of aqueous solutions |
| 05/23/2002 | WO2002040056A2 Carrageenan viscoelastics for ocular surgery |
| 05/23/2002 | WO2002040055A2 Solutions and films of glycated chitosan |
| 05/23/2002 | WO2002040054A1 Pharmaceutical preparation containing copolyvidone |
| 05/23/2002 | WO2002040051A1 Colostrum-based composition |
| 05/23/2002 | WO2002040041A2 Orally ingestible preparation of mistletoe lectins and method |
| 05/23/2002 | WO2002040040A1 Camptothecin compounds with a sulfhydryl group |
| 05/23/2002 | WO2002040039A2 In vivo use of water absorbent polymers |
| 05/23/2002 | WO2002040036A1 Preventives or remedies for endometriosis or uterine myoma |
| 05/23/2002 | WO2002040035A1 Remedies for diabetes |
| 05/23/2002 | WO2002040034A1 Complexes of phosphate derivatives |
| 05/23/2002 | WO2002040033A1 Formulation containing phosphate derivatives of electron transfer agents |
| 05/23/2002 | WO2002040032A2 Cytoprotective estrogen derivatives |
| 05/23/2002 | WO2002040030A1 Combination therapy for lowering and controlling intraocular pressure |
| 05/23/2002 | WO2002040029A2 Corticosteroids adducts with natural polysaccharide polymers |
| 05/23/2002 | WO2002040028A1 Antibacterial gel eye drops |
| 05/23/2002 | WO2002040027A1 Treatment of premature ejaculation |